<<
>>

THE LITERATURE LIST

1. Agapov, V.S.Perspektivy of ozonotherapy application in complex treatment of traumatic damages of bones of a facial skeleton [Text] / V.S.Agapov, A.I.Volozhin, M.S.Agababaev//Modern problems of stomatology: sb.

nauchn. tr. To V.N.Kopejkina's 70 anniversary. - Moscow, 1999. - 2с.

2. Agapov, V.S.Primenenie of medical ozone in complex treatment of chronic and flaccid purulent infectious-inflammatory diseases maxillofacial areas [Text] / V.S.Agapov, V.V. Shulakov, S.N.Smirnov, N.A.Fomchenkov//the Wedge. Stomatology. - 2000. - №3. - with. 22-25.

3. Agapov, V.S.Ozonoterapija of chronic osteomyelites of a mandible [Text] / V.S.Agapov, V.V. Shulakov, N.A.Fomchenkov//Stomatology. - 2001. - №5. - with. 14-17.

4. Akulich, I.I.ozonotherap in complex treatment paranazalnyh sinusitises: an autoref. dis.... kand. Medical sciences: 14.00.04 / Akulich Ivan Ivanovich. - M, 1997. - 21 with.

5. Andous, V.N.Effektivnost of ozone against microorganisms on the test - surfaces [Text] / V.N.Andous//Ekologo-epidemiological supervision of prirodno-focal infections in Northern Prikaspii: sb. nauch. Work. - Astrakhan, 1996. - With. 154.

6. Apsatarov, E.A.ozonotherap surgical infections [Text] / E.A.Apsatarov, S.A.Zhamalov, A.K.Alimzhanov, C.C.Bekishev//Pressing questions of a surgical infection: a floor-mat. nauch.-praktich. konf. - Semipalatinsk, 1991. - S.16-17.

7. Atrushkevich, V.G.Ispolzovanie of preparations for correction of the mineral
Exchange in complex treatment of diseases parodonta [Text] of/century G.Atrushkevich, E.V.Zorjan, O.L.Velichenko//XV Russian national congress «the Person and a medicine»: sb. Materials kongr, Moscow, on April, 14-18th, 2008 - M, 2008. - With. 31.

8. Basin, E.M.osteonecros of bones of a facial skeleton at persons with narcotic dependence (clinic, diagnostics, treatment) [Text]: dis.... kand. Medical sciences: 14.01.14 / Basin Evgenie Mihajlovich. - M, 2012. - 137 with.

9. Bazhanov, N.N.indicator of phagocytic activity of neutrophils of blood depending on character of a clinical current of dontogenous phlegmons [Text] / N.N.Bazhan, A.K.Chikorin, V.V. Berchenko//Stomatologija. - 1987. - łz. - With. 32-34.

10. Belokurov, JU.N.ozonotherap of purulent wounds [Text] / J.N.Belokurov, Molodkin V. M//Ozone in biology and medicine: mater II All-Russia nauchn. prakt. konf. - N.Novgorod, 1998. - With. 29-30.

11. Bolgov, V.F.Sostojanie of functional activity nejtrofilnyh leucocytes in ranevom separated against ozonotherapies [Text] / V.F.Bolgov, S.I.Miroshin//Ozone in biology and medicine: a floor-mat. vtor. Vseros. konf. With mezhdunar. uch. - N.Novgorod, 1995. - With. 9-10.

12. Bondaruk, O.I.Effektivnost zolendronata at treatment of a metastatic lesion of bones at patients with various primary tumours / O.I.Bondaruk, O.Ponomareva, N.Ogorodnikova, A.Moskalets//Oncology. - 2006. - Т.8, №4. - with. 348-354.

13. Wolves, A.V.Gistomorfometrija of an osteal tissue in regenerative medicine / A.V.wol, G.B.Bolshakova//Clinical and experimental morphology. - 2013. - № 3 (7). - with. 65-72.

14. Volozhin, A.I.role of phagocytosis activation in the mechanism of medical action of medical ozone at patients with flaccid purulent inflammatory processes of soft tissues maxillofacial areas [Text]//A.I.Volozhin, V.S.Agapov, V.V. Shulakov, S.N.Smirnov, T.I.Sashkina//Stomatology.

- 2001. - №6. - with. 22-24.

15. Humpbacks, S.N.possibilit of use of medical ozone in military medicine and medicine of accidents [Text] / S.N. Humpbacks, S.P.peretjagin. - N.Novgorod, 1996.

16. Gunko, M.V.Osteoporoz and dentalnaja implantation [Text] / M.V.Gunko//Stomatology. - 2009. - №6. - with. 73-78.

17. Durnovo, E.A.substantiation of ozone use in complex treatment of phlegmons of the person and a neck: an autoref. dis.... kand. Medical sciences: 14.00.21/Durnovo Evgenie Aleksandrovna. - M, 1998. - 25с.

18. Durnovo, E.A.preventive maintenance of inflammatory complications of open fractures of a mandible with use ozonotherapies [Text] / E.A.Durnovo, I.D.Kinjapina, N.E.Homutinnikova//Tr. VI congress Stomat. assots. Russia. - Moscow, 2000. - With. 299-301.

19. Dymnikov, A.B.Osteonekroz of a mandible after an exodontia at the patients receiving therapy bisfosfonatami / A.B.Dymnikov, N.A.Zhukov (N.A.Zaslavsky), L.G.Masur, A.V.Vinogradov, S.V.Tarasenko//bulletin RONTS of N.N.Blohina. - 2009. - Volume 20. - №2. - the Appendix 1. - [Mat.evraz.kongr. On has swelled up. Heads and necks, Resp. Belarus, Minsk] — With. 133.

20. Efanov, O.I.Poluchenie of ozone by means of ultra-violet radiation and parametres of dosage procedures [Text] / O.I.Efanov, A.G.wol, N.Z.Dikopova, V.V. Nosov, A.A.Tretjakov//Formation, a science and practice in stomatology on incorporated subjects: the Healthy way of life from early age. Ways of improvement of quality of the stomatologic help »: sb. tr. 9th Vseros. nauch.-prakt.konf. / under the editorship of O.O.Janushevicha, I.J.Lebedenko. - SPb.: the person, 2012. - C. 85-86.

21. Efanov, O.I.Issledovanie of antibacterial activity of ozone invitro [Text] / O.I.Efanov, A.G.wol, N.Z.Dikopova, A.A.Tretjakov//formation, a science and practice in stomatology »on uniform subjects« Stomatology and socially significant diseases: sb. tr. X Vseros. Nauch. - prakt. konf. - M, 2013. - With. 86.

22. ZHabina, A.S.role bisfosfonatov for preventive maintenance and treatment of metastasises in bones [Text] / A.S.Zhabina//Practical oncology. - 2011. - Т.12, №3. - with. 124-131.

23. Zhukov, N.V.addition to preparation chemotherapy zometa considerably enlarges the general survival rate earlier not treated sick of a plural myeloma / N.V.Zhukov//Farmateka. - 2010. № 17. - With. 78­80.

24. Hares, A.B.local ozonotherapy in the complex surgical

Treatment of patients with a chronic osteomyelitis [Test] / A.B.hare//the Nizhniy Novgorod medical magazine. - 2003. - the appendix,

"Ozonotherapy". - With. 207-208.

25. Zaslavsky, N.A.experience of treatment of patients bisfosfonatnymi

Osteonecroses of jaws with ozonotherapy application / N.A.Zaslavsky,

A.J.Drobyshev, A.G.wol, N.Z.Dikopova, Etc. SHipkova, R.Z.Saberov, I.D.Zaslavsky//New technologies in stomatology: mater. XVIII mezhdunarod. konf. The people of-persons. hir. And stomat., St.-Petersburg, on May, 14-16th, 2013 - SPb., 2013. - with. 69-70.

26. Zaslavsky N.A.experience of ozonotherapy application at treatment bisfosfonatnyh osteonecroses of jaws at patients with a malignant pathology in the anamnesis [Text] / N.A.Zaslavsky, A.J.Drobyshev, A.G.wol, N.Z.Dikopova, Etc. SHipkova//Dental Forum. - 2013. - №3. - [Materials XXXV result. nauch. konf. Young uchenyhmgmsu of A.I.Evdokimova]. - with. 45.

27. Zaslavsky, N.A.problem of timely diagnostics and treatment of osteonecroses of jaws at sick of the malignant neoplasms, receiving antirezorbtivnuju therapy [Text] / N.A.Zaslavsky, A.J.Drobyshev, A.G.wol, D.A.Lezhnev, N.Z.Dikopova//XXI Russian national congress «the Person and a medicine»: sborn. A floor-mat. kongr. (Theses dokl.). - M, 2014. - with. 131.

28. Zaslavsky, N.A.diagnostics and treatment osteonerozov jaws at patients
The malignant neoplasms, receiving therapy antirezorbtivnymi preparations (bisfosfonaty, denosumab) [Text] / N.A.Zaslavsky, A.J.Drobyshev, A.G.wol, D.A.Lezhnev//the Medical bulletin of the Ministry of Internal Affairs. - 2014. - volume LXVIII, №1 (68). - With. 14-16.

29. Zaslavsky, N.A.experience of treatment of osteonecroses of jaws at the patients receiving antirezorbtivnuju therapy (bisfosfonaty, "Denosumab") [Text] / N.A.Zaslavsky, A.J.Drobyshev, A.G.wol//Cathedra. - 2014.

- №47. - WITH. 32-34.

30. Zaslavsky, N.A.experience of treatment of the patient sick bisfosfonatnym of an osteonecrosis of a jaw against a chronic periodontitis of teeth of a mandible (clinical observation) [Text] / N.A.Zaslavsky, A.J.Drobyshev, D.A.Lezhnev, A.G.wol, S.V.Tarasenko//Endodontija Today.

- 2014 - №2. - WITH. 22-26.

31. Malignant neoplasms in Russia in 2012 (a case rate and a mortality) [Text] / under the editorship of A.D.Kaprin

M: FGBU «MNIOI of P.A.Herzen» Ministry of Health of Russia,

32. Zubkova, I.I., Rizedronat in osteoporosis treatment: efficiency and shipping [Text] / I.I.Zubkova, J.A.Safonova, E.G.Zotkin//Farmateka. - 2012. - № 16. - With. 51-55.

33. Idov, I.E.medical of property of ozone [Text] / I.E.Idov//Medical news. - 1998. - №1. - with. 90-94.

34. Kaler, G.V.Vzaimodejstvie of ozone with membranes of erythrocytes [Text] / G.V.Kaler, A.M. Millers, V.K.Matus, With. V.Konev//Biol. Medicine. - 1989. - Т.6, №11. - S.1164-1169.

35. Kinjapina, I.D.use of ozonotherapy in complex treatment of inflammatory dontogenous diseases maxillofacial areas [Text] / I.D.Kinjapina, E.A.Durnova//the Kazan bulletin of stomatology. - 1996. - №2. - with. 93.

36. Koksharov, I.A.caus ozone of change of physical parametres
Erythrocyte membranes. Dozozavisimye effects [Text] / I.A.Koksharov, S.P.peretjagin, V.G.Jahno//Ozone in biology and medicine: tez. 1 Vseros. nauchn. prakt. konf. - N.Novgorod, 1992. - With. 15-16.

37. Koltsov, V.S.Primenenie of the ozonized solutions for treatment of acute purulent inflammatory diseases maxillofacial areas [Text] /

V.S.Koltsov, J.V.Veretelnikov//Pressing questions reconstructive and a plastic surgery: sb. A result. nauch. The slave. - Irkutsk, 1999. - With. 38-40.

38. Kondratyev, Century B, Metastasises in a bone: the complicated forms, a hypercalcemia, a syndrome of a compression of a spinal cord, medicamental treatment [Text] / V.B.Kondratyev, V.V. Martynjuk, L.A. Whether//Practical oncology. - 2000. - № 2. - with. 41-45.

39. Kondratyev, A.P.core aspects of application bisfosfonatov in oncology [Text]//Modern oncology. - 2005. - №2. - with. 87-88.

40. Konstantinoma, M.M.Novye supporting agents (antiemetic, bisfosfonaty, colony stimulating factors) [Text] / M.M.Konstantinova//Practical oncology. - 2002. - Т.3, №2. - with. 309-319.

41. Short, N.G.influence of ozone on microbiological characteristics of a stomatic liquid at patients with fractures of a mandible [Test] / N.G.short, O.V.Lazutikov, V.V. Dmitriev//Stomatology. - 2000. - №2. - with. 20-21.

42. Red, A.G.ozonotherap in complex treatment of fractures of a mandible: an autoref. dis.... kand. Medical sciences: 14.00.27, 14.00.21 / Red Alexander Grigorevich. - M, 2000. - 27с.

43. Lazutnikov, O.V.Primenenie of solutions barbotirovannyh ozone in treatment of primary purulent wounds of maxillofacial area and a neck: an autoref. dis.... kand. Medical sciences: 14.00.21, 14.00.27 / Lazutnikov Oleg Vladimirovich. - Voronezh, 1997. - 26с.

44. Lepilin, A.V.experience of ozonotherapy application at chronic generalised parodontite [Text] / A.V.Lepilin, D.V.Kargin, I.V.Kozlova//Modern high technologies. - 2005. - №10. - S.46-47.

45. Mkrtumjan, And. M.Bisfosfonaty in therapy of an osteoporosis [Text] / And. M.Mkrtumjan, E. V.Birjukova//probl. Endocrinologies. - 2008. - Т.54, № 3. -

C. 51-55.

46. Minenkov, A.A.main principle and tactics ozonotherapies [Text] / A.A.Minenkov. - M, 2001. - 36 with.

47. Movsesjan, G.V.Primenenie of medical ozone in complex treatment of phlegmons of maxillofacial area: an autoref. dis. kand. Medical sciences: 14.00.21 / MovsesjanGaregin Vachaganovich. - M, 2001. - 22 with.

48. Nikitin, V.G.Primenenie of ozonotherapy in complex treatment of acute pyoinflammatory diseases of soft tissues: an autoref. dis. kand. Medical sciences: 14.00.21 / Nikitin Vyacheslav Gennadevich. - M, 2001. - 31с.

49. Konstantinova, M.M. New supporting agents (antiemetic, bisfosfonaty, colony stimulating factors) [Text] / M.M.Konstantinova//Practical oncology. - 2002 - Т.3, № 4. - With. 309-319.

50. Bases of radial therapy and some private questions of treatment of malignant tumours [Text]: uch.-metodich. The grant / under the editorship of J.I.Vorobeva. - Moscow, 1996. - 94с.

51. Pashenkov, V.D.Vlijanie of ozone ia leucocytes the person [Text] / V.D.Pashenkov, A.V.Simonov, S.P.Radko//Ozone in biology and medicine: mater. I Vseros. Nauchn. - prakt. konf. - N.Novgorod., 1992. - S.4-5.

52. Pereverzev, A.S.osteal metastasises of a cancer of a prostate: a pathogenesis, diagnostics, treatment [Text] / A.S.Pereverzev, A.N.Dubinin//Zdorov'ja Ukra§ni. - 2012. - № 3. - With. 30-32.

53. peretjagin, S.P.mechanism of medical action of ozone at hypoxias [Text] / S.P.peretjagin//Ozone in biology and medicine: tez. dokl. I Vseross. Nauch - prakt. konf. - N.Novgorod, 1991. - With. 4-5.

54. Pershin, A.V.complex treatment of patients with dontogenous phlegmons of maxillofacial area with use ozonoyoultrazvukovyh technologies: dis. kand. Medical sciences: 14.00.21 / Pershin Andrey Vasilevich. - Omsk, 2000. - 158 with.

55. Petrov, G.M.Effektivnost of application of preparations of ozone in complex treatment paranazalnyh sinusitises [Text] / G.M.Petrov, B.P.Kudryavtsev, I.I.Akulich//Voen. Medical magazine. - 1996. - Т.37, №12. - with. 26-28.

56. povoroznjuk, V.V. Bisfosfonaty: a role ibandronovoj acids in treatment postmenopauzalnogo an osteoporosis [Text] / V.V. Povoroznjuk//Zdorov'ja Ukra§ni. - 2007. - № 5. - With. 57-58.

57. Rabinovich, S.A.modern of technology of a local anaesthesia in stomatology [Text] / S.A.Rabinovich - M: VUNMTS MZ the Russian Federation, 2000. - 144 with.

58. Razumovsky, S.D.ozone and its reactions with organic bonds [Text] / S.D.Razumovsky, G.E.Zamkov - M: the Science, 1974. - 322с.

59. Starlings, V.V. Diagnostika and osteoporosis treatment: focus on bisfosfonaty [Text] / V.V. Skvortsov, V.V. Odintsov, E.M.Skvortsova//the Directory of the doctor of the general practice. - 2011. - №1. - with. 31-34.

60. Smirnov, S.N.application of medical ozone in complex treatment of the limited flaccid inflammatory processes of soft tissues cheljustno - facial area: dis.... kand. Medical sciences: 14.00.21 / Smirnov Sergey Nikolaevich. - Moscow, 1999. - 158 with.

61. Spiridonov, T.G.local ozono-oxygen therapy in complex treatment of combustions of extremities: dis.... kand. Medical sciences: 14.00.27 / Spiridonov Tamara Georgievna. - Moscow, 1994. - 158 with.

62. Suhovolsky, R.P.Toksicheskoe phosphorus action on an oral cavity [Text] / R.P.Suhovolskaja//Soviet stomatologija. - 1934. - №4. - With. 57-68.

63. Tarasenko, S.V.experience of application Er:YAG of the laser in treatment of an osteonecrosis of a jaw at the patients receiving therapy bisfosfonatami [Text] / S.V.Tarasenko, A.B.Dymnikov, N.A.Zhukov (N.A.Zaslavsky)//Innovative approaches in the practical decision of pressing questions
Modern maxillofacial surgery and stomatology: sb. tr. resp. nauch.-prakt.konf. With mezhdunar.uch., «Parinsky readings», Minsk, on May, 6th, 2010 - Minsk: publishing house BGU, 2010. - With. 53-55.

64. Tarasenko, S.V.tactics of treatment of patients with bisfosfonatnym an osteonecrosis of jaws [Text] / S.V.Tarasenko, A.J.Drobyshev, Etc. SHipkova, N.A.Zhukov (N.A.Zaslavsky), I.V.Tarasenko//the Russian stomatology. - 2012. - №2. - with. 3-13.

65. Toroptsova, N.V., Bisfosfonaty and their role in preventive maintenance of fractures at women with postmenopauzalnym an osteoporosis [Text] / N.V.Toroptsova, L.I.Benevolensky//Russian medical magazine: the independent edition for practising doctors. - 2008. - volume 16, № 10. - With. 680-683.

66. Truhacheva, T.V.kinetic of pattern of  destruction of microorganisms under the influence of ozone [Text] / T.V.Truhacheva, V.V. Gavrilov, R.A.Malama, from co-workers.//Microbiology. - 1994, - Т.4, №4. - With. 660-665.

67. Fomchenkov, N.A.application of medical ozone in complex treatment of chronic traumatic and dontogenous osteomyelites of a mandible: dis.... kand. Medical sciences: 14.00.21 / FomchenkovNikolaj Andreevich. - M, 2000. - 188с.

68. Fomchenkov, N.A.application of medical ozone in complex treatment of a chronic traumatic and dontogenous osteomyelitis of a mandible: an autoref. diss.... kand. Medical sciences: 14.00.21 / Fomchenkov Nikolay Andreevich. - Moscow, 2001. - 26с.

69. Frenchmen, V.N.Ozonoterapija in kospleksnom treatment anaerobic neklostridialnoj infections of soft tissues [Text] / V.N.Frantsuzov, A.A.Novozhilov//Voen. Medical magazine. - 1997. - №11. - with. 54.

70. Homutinnikova, N.E.treatment of patients with otkrytimi fractures of a mandible and preventive maintenance of posttraumatic inflammatory complications with ozonotherapy use: dis.... kand. Medical sciences: 14.00.21 / Homutinnikova Nina Evgenevna. - N.Novgorod, 2002. - 185с.

71. CHernohvostova, E.V.research of immunoglobulins and other fibers in secrets the person [Text] / Methodical references. MZ RSFSR. M, 1987. - 35с.

72. Shimanovsky, N.L., New possibilities in treatment bisfosfonatami osteal complications at a malignant innidiation: Bonefos - a preparation of a choice [Text] / N.L.Shimanovsky, J.A.Svishchenko//Palliative medicine and aftertreatment. - 2001. - № 4. - with. 67-74.

73. SHulakov, V.V. Immunostimulirujushchee ozone action at treatment of a flaccid purulent inflammation maxillofacial areas [Text] / V.V. Shulakov, S.N.Smirnov, V.S.Agapov//stomatology Questions: sb. posvjashch. To the 70 anniversary of prof. E.S.Tikhonov. - Ryazan, 1998г. - With. 309-311.

74. The encyclopaedia of clinical oncology: the Management for practising doctors / M.I.Davidov, G.L.Vyshkovsky, etc.; under obshch. red. M.I.Davidov, G.L.Vyshkovskogo. - M: РЛС-2005, 2004 - 1536 with.

75. Abu-ID, M.H. «Bis-phossy jaws» - high and low risk factors for BISPHOSPHONATE - induced osteonecrosis of the jaw [Text] / M.H. Abu-ID, P.H. Warnke, J. Gottschalk [et al.]//J. Craniomaxillofac. Surg. - 2008. - N 36. - P. 95-103.

76. Agis, H. Is zoledronate toxic to human periodontal fibroblasts? [Text] / H. Agis, J. Blei, G. Watzek, R. Gruber//J. Dent. Res. - 2010.-N89 (1). - THE RIVER 40-45.

77. Agrillo, A. New therapeutic protocol in the treatment of avascular necrosis of the jaws [Text] / A. Agrillo, M.T. Petrucci, M. Tedaldi [et al.]//J. Craniofacial.

Surg. - 2006. - N17 (6). - P1080-1083.

78. Agrillo, A. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis [Text] / A. Agrillo, C. Ungari, F. Filiaci, P. Priore, G. Iannetti//J. Craniofacial. Surg. - 2007. - N18 (5). - P.1071-1075.

79. Agrillo, A. Ozone therapy in extractive surgery on patients treated with bisphosphonates [Text] / A. Agrillo, P. Sassano, C. Rinna, P. Priore, G. Iannetti//J. Craniofacial. Surg. - 2007. - N18 (5). - P.1068-1070.

80. Alakangas, A. Alendronate disturbs vesicular trafficking in osteoclasts [Text] /

A. Alakangas, K. Selander, M. Mulari [et al.]//Calcif. Tissue Int. - 2002. - N70.

- THE RIVER 40-47.

81. Allen, M.R. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data [Text] / M.R. Allen, D.B. Burr//J. Oral Maxillofac. Surg. - 2009. - N67. - P.61-70.

82. Allen, M.R. Bisphosphonate effects on bone turnover, microdamage, andmechanical properties: What we think we know and what we know that we don'tknow [Text] / M.R. Allen, D.B. Burr//Bone. - 2011. - N49 (1). - THE RIVER 56-65.

83. Almazrooa, S.A. Bisphosphonate and nonbisphosphonate-associated

osteonecrosis of the jaw: a review [Text] / S.A. Almazrooa, S.B. Woo//J. Am. Dent. Assoc. - 2009. - N 140 (7). - THE RIVER 864-875.

84. Alons, K. Treating LOW - and medium-potency bisphosphonate-relatedosteonecrosis of the jaws with a protocol for the treatment of chronic suppurativeosteomyelitis: report of 7 cases [Text] / K. Alons, S.C.C. Kuijpers, E. Jong, J.P. Richard van Merkesteyn.//Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. - 2009. - Vol.107, Iss. 2. - P. e1-e7.

85. Assaf, A.T. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies [Text] / A.T. Assaf, R. Smeets, B. Riecke, E. Weise [et al.]//Anticancer Res. - 2013. - N33 (9). P. 3917-3924.

86. Badros, A. Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [Text] / A. Badros, D. Weikel, A. Salama [et al.]//J. Clin. Oncol. - 2006. - N24. - THE RIVER 945-952.

87. Bamias, A. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors [Text] / E. Kastritis, C. Bamia [et al.]//J. Clin. Oncol. - 2005. - N23. - THE RIVER 8580-8587.

88. Bisphosphonates in Medical Practice [Text] / R.Bartl, B. Frisch, E. von Tresckow, C. Bartl. - Springer, 2007. - 265p.

89. Bedogni, A. Bisphosphonate-associated osteonecrosis can hide jaw mestastases [Text] / A. Bedogni, G. Saia, M. Ragazzo, G. Betini [et al.]//Bone. - 2007. - N41 (6). - P.942-945.

90. Berenson, J.R. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [Text] / J.R. Berenson, A. Lichtenstein, L. Porter [et al.]//N. Engl. J. Med. - 1996. - Vol. 334, N8. - P.488-493.

91. Bertoldo, F. Bisphosphonates and osteomyelitis of the jaw: A pathogenic puzzle [Text] / F. Bertoldo, D. Santini V. LoCascio//Nat. Clin. Pract. Oncol. - 2007. - N4. - P. 711-721.

92. Bisdas, S. Bisphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients [Text] / S. Bisdas, N. Chambron Pinho, A. Smolarz, R. Sader, T.J. Vogl, M.G. Mack//Clin. Radiol. - 2008. - N 63. - P. 71­77.

93. Bocci V. Ozone as bioregulator: Pharmacology and toxicology of ozone-therapy today [Text] V. Bocci//J. Biol. Regul. Homeost. Agents. - 1996. - N10. - P. 31-53.

94. Bisphosphonates and osteonecrosis of the jaw: a multidisciplinary approach [Text] / F.S. De Ponte. - Springer, 2011. - 194p.

95. Borgioli, A. Bisphosphonate-related osteonecrosis of the jaw: the Florence experience [Text] / A. Borgioli, M. Duvina, L. Brancato [et al.]//Clin. Cases Miner. Bone Metab. - 2007. - N4 (1). - THE RIVER 48-52.

96. Brown, J. Risk fsctors for developing osteonecrosis of the jaw (ONJ) in patients receiving denosumab or zoledronic acid for bone metastases: Results from three phase 3 trials [Text] / J. Brown, F. Saad, A. Stopeck [et al.]//The European Cancer Congress 2013, Sep 30. - Abstract 1305.

97. Chapurlat, R.D. Drug insight: bisphosphonates for postmenopausal osteoporosis [Text] / R.D. Chapurlat, P.D. Ddelmas//Nat. Clin. Pract. Endocrinol. Metab. -

2006. - N2. - P.211-219.

98. Chiandussi, S. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws [Text] / S. Chiandussi, M. Biasotto, F. Dore, F. Cavalli [et al.]//Dentomaxillofac. Radiol. - 2006. - N35. - P.236-243.

99. Coxon, F.P. Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs [Text] / F.P. Coxon, H.L. Benford, R.G.G.

Russel, M.J. Rogers//Mol. Pharmacol. - 1998. - N54. - P. 631-638.

100. Coxon, F.P. Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages [Text] / F.P. Coxon, M.H. Helfrich, B. Larjani//J. Biol. Chem. - 2001. - N276. - THE RIVER 48213-48222.

101. Goxon, F.P. Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localisation of Rab proteins in osteoclasts in vitro and in vivo [Text] / F.P. Coxon, F.H. Ebetino, E.H. Mules [et al.]//Bone. - 2005. - N37. - THE RIVER 349-358.

102. Diego, R. Bisphosphonate-associated osteonecrosis of the jaws: atherapeutic dilemma [Text] / R. Diego, O. D’Orto, D. Pagani, A. Agazzi [et al.]//Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. - 2007. - Vol.103, Iss. 3, March. - P.e1-e5.

103. Dimopoulos, M.A. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid [Text] / M.A Dimopoulos, E. Kastritis, A. Anagnostopoulos [et al.]//Haematologica. - 2006. - N91. - THE RIVER 968-971.

104. Dore, F. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonrcrosis of the jaw [Text] / F. Dore, L. Filippi, M. Biasotto, S. Chiandussi//J.Nucl. Med. - 2009. - N 50. - P.30-35.

105. Durie, B.G.M. Osteonecrosis of the jaws and bisphosphonates [Text] /

B. G.M. Durie, M. Katz, J. Crowley//N. Engl. J. Med. - 2005. - N353. - P.99­102.

106. Eberhardt, H.G. The efficacy of ozone therapy as antibiotic [Text] / H.G. Eberhardt//Ozon World Congressman Franciesco - 1993. - THE RIVER 18-26.

107. Elad, S. Bisphosphonate-associated osteonecrosis of the jaw: clinical correlations with computerised tomography presentation [Text] / S. Elad, M.J. Gomori, N. Ben-Ami//Clin. Oral Investig. - 2010. - N14. - P.43-50.

108. Engroff, S.L. Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction? [Text] / S.L. Engroff, D.D.

Kim//J. Oral. Maxillofac. Surg. - 2007. - N65 (11). - P.2374-2385.

109. Epstein, M.S. Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series [Text] / M.S. Epstein, F.W. Wicknick, J.B. Epstein [et al.]//Oral Surg. Oral Med. Oral Pathol. Oral Rad. and Endod. - 2010. - N110 (5). - P.593-596.

110. Estilio, C.L. Osteonecrosis of the maxilla and mandible in patients treated with bisphosphonates: a retrospective study [Text] / C.L. Estilio, C.H. Van Posnak, T. Williams [et al.]//J. Clin. Oncol. Proc. Am. Soc. Clin. Oncol. - 2004.-Vol. 22. - THE RIVER 8088a.

111. Estilo, C.L. Osteonecrosis of the jaw related to bevacizumab [Text] / C.L. Estilo, N. Fornier, A. Farooki [et al.]//J. Clin. Oncol. - 2008. - N 26 (24). - P. 4037-4038.

112. Estilo, C.L. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy [Text] / C.L. Estilio, C.H. Van Posnak, T. Williams [et al.]//Oncologist. - 2008. - N13 (8). - P. 911-920.

113. Favia, G. Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: An analysis of 31 cases with confocal laserscanning microscopy [Text] / G. Favia, G.P. Pilolli, E. Maiorano//Bone. - 2009. - Volume 45, Issue 3. - P. 406-413.

114. Ferlito, S. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series [Text] / S. Ferlito, C. Liardo, S. Puzzo//Minerva Stomatol. - 2010. - N59 (11-12). - P.593-601.

115. Fleisch, H. Mechanisms of action of the bisphosphonates [Text] / H.Fleisch//Medicina (B. Aires). - 1997. - N57, Suppl.1. - P.65-75.

116. Fleish, H. The role of bisphosphonates in breast cancer: development of bisphosphonates [Text] / H. Fleish//Breast Cancer Res. - 2002. - N4 (1). - THE RIVER 30­34.

117. Fournier, P. Bisphosphonates inhibit angiogenesis in vitro and TESTOSTERONE - stimulated vascular regrowth in the ventral prostate in castrated rats [Text] / P.

Fournier, S. Boissier, S. Filleur [et al.]//Cancer Res. - 2002. - N62. - THE RIVER 6538­6544.

118. Garcia-Ferrer, L. MRI of mandibular osteonecrosis secondary to bisphosphonates [Text] / L. Garcia-Ferrer, J.V. Bagan V. Martinez-Sanjuan [et al.]//Am J. Rentgenol. - 2008. - N190. - P.949-955.

119. Gourion-Arsiquaud, S. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity [Text] / S. GOURION - Arsiquaud, M.R.Allen, D.B. Burr, D. Vashishth//Bone. - 2010. - N46 (3). - THE RIVER 666-672.

120. Green, J.R. Bisphosphonates: Preclinical review [Text] / J.R. Green//Oncologist. - 2004. - N9. - THE RIVER 3-13.

121. Greuter, S. Bevacizumab-associated osteonecrosis of the jaw [Text] / S. Greuter, F. Schmid, T. Ruhstaller [et al.]//Ann. Oncol. - 2008. - N19 (12). - P. 2091-2092.

122. Hansen, T. Osteonecrosis of the jaws in patients treated with bisphosphonates — Histomorphologic analysis in comparison with infected osteoradionecrosis [Text] / T. Hansen, M. Kunkel, A. Weber, C. James Kirkpatrick//J. Oral Pathol. Med. - 2006. - N 35. - THE RIVER 155-160.

123. Heufelder, M.J. Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw [Text] / M.J. Heufelder, J. Hendricks, T. Remmerbach [et al.]//Oral Surg Oral Med Oral Pathol Oral Radiol. - 2014. - N117 (6). - P.e429-435.

124. Hewitt, C. Bisphosphonate-related osteonecrosis of the jaws: A comprehensive review [Text] / C. Hewitt, C.S. Farah//J. Oral Pathol. Med. -

2007. - N36. - P. 319-328.

125. Hoff, A.O. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates [Text] / A.O. Hoff, B.B. Toth, K. Altunbag [et al.]//J. Bone Miner. Res. - 2008. - N 23. - P.826-836.

126. Hoff, A.O. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients [Text] / A.O. Hoff, B. Toth, M. Hu [et al.]//Ann N Y Acad Sci. - 2011. - N1218. - P.47-54.

127. Jadu, F. A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients [Text] / F. Jadu, L. Lee, M. Pharoah, D. Reece, L. Wang//Ann. Oncol. - 2007. - N18. - THE RIVER 2015-2019.

128. Khan, A.A. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. Canadian Association of Oral and Maxillofacial Surgeons [Text] / A.A. Khan, G.K. Sandor, E. Dore, A.D. Morrison [et al.]//J. Rheumatol. - 2008. - N35 (7). - THE RIVER 1391-1397.

129. Khosla, S. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research [Text] / S. Khosla, D. Burr, J. Cauley [et al.]//J. Bone. Miner. Res. - 2007. - N 22. - P. 1479 1491.

130. Koch, F.P. The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro [Electronic resource] / F. Koch, S.S. Yekta,

C. Merkel [et al.]//Head Face Med. - 2010. - Vol.6 - 12. - access: http://www.head-face-med.com/content/6/1/12.

131. Koch, F.P. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro [Text] / F.P. Koch, C. Merkel, T. Ziebart, R. Smeets [et al.]//Clin. Oral Investig. - 2012. - N16 (1). - THE RIVER 79-86.

132. Kos, M. Association of dental and periodontal status with BISPHOSPHONATE - related osteonecrosis of the jaws. A retrospective case controlled study [Text] / M. Kos//Arch. Med. Sci. - 2014. - N 10 (1). - P.117-123.

133. Kruger, T.B. Bisphosphonate-related osteonecrosis of the jaw in four Nordic countries and an indication of under-reporting [Text] / T.B. Kruger, M.N. Sharikabad, B.B.//Acta. Odontol. Scand. - 2013. - N71 (6). - THE RIVER 1386-1390.

134. Kyrgidis, A. Bisphosphonaterelated osteonecrosis of the jaws: a case­
control study of risk factors in breast cancer patients [Text] / A. Kyrgidis, K. Vahtsevanos, G. Koloutsos [et al.]//J. Clin. Oncol. - 2008. - N 26, - P. 4634­4648.

135. Lee, J.K. Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report [Text] / J.K. Lee, K.W. Kim, J.Y. Choi [et al.]//J. Korean Assoc. Oral Maxillofac. Surg. - 2013. - N 39 (1). - THE RIVER 9-13.

136. Lerman, M.A. Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes [Text] / M.A. Lerman, W. Xie, N.S. Treister [et al.]//Oral Oncol. - 2013. - N49 (9). - P.977-983.

137. Lesclous, P.Bisphosphonate-associated osteonecrosis of the jaw: A key roleof inflammation? [Text] / P. Lesclous, S.A. Najm, J.-P. Carrel, B. Baroukh [et al.]//Bone. - 2009. - Volume 45, Issue 5. - P. 843-852.

138. Malden, N. Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algoritm [Text] / N. Malden, C. Beltes V. Lopes//Brit. Dent. Journal. - 2009. - N2, Vol. 206. - P. 93-98.

139. Mancini, G. Immuno-chemical quantitation of antogens by single radial immunodiffusion [Text] / G. Mancini, A.O. Garbonara, S.F. Heremans//Immunochemistry. - 1965. - Vol. 2, N 6. - P. 234-235.

140. Maruotti, N. Bisphosphonates: effects on osteoblast [Text] / N. Maruotti, A. Corrado, A. Neve, F.P. Cantatore//Eur. J. Clin. Pharmacol. — 2012. — Vol. 68, № 7. — P. 1013-1018.

141. Marx, R.E. Oral and maxillofacial pathology: a rationale for diagnosis and treatment [Text] / R.E. Marx, D. Stern.//Chicago: Quintessence Publishing. - 2003. - 908 p.

142. Marx, R.E. Pamidronate (Aredia) and zoledronate (Zometa) IN - duced avascular necrosis of the jaws: A growing epidemic [Text] / R.E. Marx//J. Oral. Maxillofac. Surg. - 2003. - N61. - P. 1115-1117.

143. Marx, R.E. Bisphosphonate induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment [Text] / R.E. Marx, Y. Sawatari, M. Fortin [et al.]//J. Oral

Maxillofac. Surg. - 2005. - N63. - P. 1567-1575.

144. Marx, R.E. Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws [Text] / R.E. Marx//J. Oral Maxillofac. Surg. - 2009. - N67, Suppl.5. - P.107-119.

145. Mavrokokki, T. Nature frequency of bisphosphonte-associated osteonecrosis of the jaws in Australia [Text] / T. Mavrokokki, A. Cheng, B. Stein, A. Goss//J. Oral Maxillofac. Surg. - 2007. - N65 (3). - THE RIVER 415-423.

146. McArthur, H.L. Osteonecrosis of the jaw (ONJ) among intravenous (IV) bisphosphonate - and/or bevacizumab-treated patients (pts) at Memorial SLOAN - Kettering Cancer Center (MSKCC) [Text] / H.L. McArthur, C. Estilo, J. Huryn [et al.]//J. Clin. Oncol. - 2008. - N26 (155). - P. 9588.

147. Migliorati, C.A. Bisphosphanates and oral cavity avascular bone necrosis [Text] / C.A. Migliorati//J. Clin. Oncol. - 2003. - N21 (22). - P.4253-4254.

148. Migliorati, C.A. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy [Text] / C.A. Migliorati, M.M. Schubert, D.E. Peterson, L.M. Seneda//Cancer. - 2005. - N 104 (1). - Р83-93.

149. Morag, Y. Bisphosphonate-related osteonecrosis of the jaw: a pictorial review [Text] / Y. Morag, M. Morag-Hezroni, D.A. Jamadar [et al.]//Radiographics. - 2009. - N 29. - THE RIVER 1971-1984.

150. Mucke, T. Bisphosphonate related osteonecrosis of the jaws treated bysurgical resection and immediate osseous microvascular reconstruction [Text] / T. Mucke, S. Haarmann, K.-D. Wolff, F. Holzle//Journal of Cranio-Maxillofacial Surgery. - 2009. - Vol.37, Iss.5. - P. 291-297.

151. Nancollas, G.H. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite [Text] / G.H. Nancollas, R. Tang, R.J. Phipps [et al.]//Bone. - 2006. - Vol. 38, N5. - P. 617-627.

152. Nocini, P.F. Vascularized fibula flap reconstruction of the mandible in bisphosphonate-related osteonecrosis [Text] / P.F. Nocini, G. Saia, G. Bettini [et al.]//Eur. J. Surg. Oncol. - 2009. - N35 (4). - P.373-379.

153. Nomura, T., Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic [Text] / T. Nomura, T. Shibahara, T. Uchiyama [et al.]//Bull. Tokyo Dent. Coll. - 2013. - N 54 (2). - THE RIVER 117-125.

154. Orriss, I.R., Inhibition of osteoblast function in vitro by aminobisphosphonates [Text] / I.R. Orriss, M.L. Key, K.W. Colston, T.R. Arnett//J. Cell. Biochem. - 2009. - N106 (1). - P.109-118.

155. Otto, S. Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle? [Text] / S. Otto, S. Hafner, G. Mast [et al.]//J. Oral Maxillofac. Surg. - 2010. - N 68. - P.1158-1161.

156. Petrucci, M.T. Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients [Text] / M.T. Petrucci, C. Gallucci, A. Agrillo [et al.]//Haematologica. - 2007. - N92 (9). - P. 1289-1290.

157. Phal, P.M. Imagimg findings of bisphosphonate-associated osteonecrosis of the jaws [Text] / P.M. Phal, R.W. Myall, L.A. Assael, J.L. Weissman//Am. J. Neuroradiol. - 2007. - N 28. - P.1139-1145.

158. Reid, I.R. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? [Text] / I.R. Rrid, M.J. Bolland, A.B. Grey//Bone. - 2007.

- N 41. - THE RIVER 318-320.

159. Reid, I.R., Osteonecrosis of the jaw [Text] / I.R. Reid, T. Cundy//Skelet. Radiol. - 2009. - N 38. - P. 5-9.

160. Ripamonti, C. Efficacy and safety of medical ozone (O (3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study [Text] / Oral Oncol. - 2011. - N47 (3). - P.185-190.

161. Roelofs, A.J. Molecular mechanisms of action of bisphosphonates: current status [Text] / A.J. Roelofs, K. Thompson, S. Gordon//Clin. Cancer Res. - 2006.

- N12. - THE RIVER 6222s-6230s.

162. Roelofs, A.J. Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of

IPP/DMAPP [Text] / A.J. Roelofs, M. Jauhiainen, H. Monkkonen [et al.]//Br. J. Haematol. - 2009. - N144 (2). - P.245-250.

163. Rogers, M.J. Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase nzymes [Text] / M.J. Rogers, R.J. Brown V. Hodkin, G.M. Blackburn [et al.]//Biochem. Biophys. Res. Commun. - 1996. - N224. - P. 863-869.

164. Rogers, M.J. Cellular and molecular mechanisms of action ofbisphosphonates [Text] / M.J. Rogers, S. Gordon, H.L. Benford, F.P Coxon//Cancer. - 2000. - N88, Suppl. 12. - THE RIVER 2961-2978.

165. Rogers, M.J. New insights into the molecular mechanisms of action ofbisphosphonates [Text] / M.J. Rogers//Curr. Pharm. Des. - 2003. - N9 (32). - THE RIVER 2643-2658.

166. Romeo, U. Observation of pain control in patients with BISPHOSPHONATE - induced osteonecrosis using low level laser therapy: preliminary results [Text] / U. Romeo, A. Galanakis, C. Marias [et al.]//Photomed. and Laser Surg. - 2011. N29 (7). - P.447-452.

167. Ruggiero, S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases [Text] / S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg//J. Oral Maxillofac. Surg. - 2004. - N62. - P.527-534.

168. Ruggiero, S.L. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management [Text] / S.L. Ruggiero, J. Fantasia, E. Carlson//Oral Surg. Oral Med. Oral Path. Oral Radiol. Endod. - 2006. - N102. - THE RIVER 433-441.

169. Ruggiero, S.L. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update [Text]/S.L. Ruggiero, T.B. Dodson, L.A. Assael, [et al.]//J. Oral Maxillofac. Surg. - 2009. - N67, Suppl. 5. - P. 2-12.

170. Russel, R.G. Bisphosphonates: mode of action and pharmacology [Text] / R.G. Russel//Pediatrics. - 2007. - N 119. - RS150-S162.

171. Santini, D. Pamidronate induces modifications of circulating angiogenic
factors in cancer patients [Text] / D. Santini, B. Vincenzi, G. Avvisati//Clin. Cancer Res. - 2002. - N8. - P.1080-1084.

172. Sarasquete, M. BRONJ is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide analysis [Text] / M. Sarasquete//Blood. - 2008. - N112. - P.2709­2712.

173. Sato, M. Bisphosphonate action. Alendronate localisation in rat bone and effects on osteoclast ultrastructure [Text] / M. Sato, W. Grasser, N. Endo, R. Akins//J. Clin. Invest. - 1991.-N88 (6). - THE RIVER 2095-2105.

174. Saussez, S. Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series [Text] / S. Saussez, R. Javadian, C. Hupin, M. Magremanne [et al.]//Laryngoscope. - 2009. - N119 (2). - THE RIVER 323-329.

175. Scoletta, M. Effect of low-level laser irradiation on BISPHOSPHONATE - induced osteonecrosis of the jaws: preliminary results of a prospective study [Text] / M. Scoletta, P.G. Arduino, L. Reggio [et al.]//Photomed. and Laser Surg. - 2010. - N28 (2). - P.179-184.

176. Sedghizadeh, P.P. Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy [Text] / P.P. Sedghizadeh, S.K. Kumar, A. Gorur [et al.]//J. Oral Maxillofac. Surg. - 2008. - N 66. - THE RIVER 767-775.

177. Seth, R. Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonate-related osteonecrosis of the jaws [Text] / R. Seth, N.D. Futran, D.S. Alam, P.D. Knott//Laryngoscope. - 2010. - N120 (11). - P.2165-2171.

178. Shipman, C.M. Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumour activity [Text] / C.M. Shipman, M.J. Rogers, J.F. Apperley [et al.]//Br. J. Haemotol. - 1997. - N98. - THE RIVER 665 - 672.

179. Stockmann, P. Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preffered in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study [Text] / P. Stockmann, F.M. Hinkmann, M.M. Lell [et al.]//Clin. Oral. Investig.

- 2010. - N 14. - P. 311-317.

180. Store, G. Mandibular osteoradionecrosis: a comparison of computed tomography with panoramic radiography [Text] / G. Store, T.A. Larheim//Dentomaxillofac. Radiol. - 1999. - N 28. - P.295-300.

181. Tubiana-Hulin, M. Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis [Text] / M. Tubiana-Hulin, M. Spielmann, C. Roux, M. Campone [et al.]//Crit. Rev. Oncol. Hematol. - 2009. - N71 (1). - THE RIVER 12-21.

182. Vescovi, P. Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment? [Text] / P. Vescovi, E. Merigo, M. Meleti, M.Manfredi//J. of Oral and Maxillofac. Surg. - 2006. - N64 (9). - P. 1460-1462.

183. Vescovi, P. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases [Text] / P. Vescovi, E. Merigo, M.Manfredi [et al.]//Photomed. and Laser Surg. - 2008. - N26 (1). - P.37-46.

184. Walter, C. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients [Text] / C. Walter, B. Al-Nawas, A. du Bois [et al.]//Cancer. - 2009. - N115 (8). - P.1631-1637.

185. Walter, C. Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells [Text] / C. Walter, M.O. Klein, A. Pabst [et al.]//Clin. Oral. Investig. - 2010. - N 14. - THE RIVER 35-41.

186. Wang, G. Osteonecrosis of the jaws associated with cancer chemotherapy [Text] / G. Wang//J. Oral. Maxillofac. Surg. - 2003. - N61 (9). - P.1104-1107.

187. Wessel, J.H. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: A case-control study / J.H. Wessel, T.B. Dodson, A.I. Zavras//J. Oral Maxillofac. Surg. - 2008. - N66. - THE RIVER 625-631.

188. Woo, S.B. Osteonecrosis of the jaw and bisphosphonates [Text] / S.B. Woo, K. Hande, P.G. Richardson//N. Engl. J. Med. - 2005. - N 353 (1). - THE RIVER 99­102.

189. Wood, J. Novel antiangiogenic effects of the bisphosphonate compound
zoledronic acid [Text] / J. Wood, K. Bonjean, S. Ruetz [et al.]//J. Pharmacol. Exp. Ther. - 2002. - N302. - THE RIVER 1055-1061.

190. Zimolo, Z.Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin [Text] / Z. Zimolo, G. Wesolowski, G.A. Rodan//J. Clin. Invest. - 1995. - N96 (5). - THE RIVER 2277-2283.

<< | >>
Scientific source ZASLAVSKAYA NATALIA ALEKSANDROVNA. OPTIMIZATION of PREVENTIVE MAINTENANCE And TREATMENT BISFOSFONATNYH of OSTEONECROSES of JAWS At PATIENTS WITH MALIGNANT NEOPLASMS. The dissertation on competition of a scientific degree of the candidate of medical sciences. Moscow - 2014. 2014

Other medical related information THE LITERATURE LIST:

  1. THE LITERATURE LIST
  2. THE LITERATURE LIST
  3. THE LITERATURE LIST
  4. THE LITERATURE LIST
  5. THE LITERATURE LIST
  6. THE LITERATURE LIST
  7. THE LITERATURE LIST
  8. THE LITERATURE LIST
  9. THE LITERATURE LIST:
  10. THE LITERATURE LIST:
  11. THE LITERATURE LIST
  12. THE LITERATURE LIST
  13. THE LITERATURE LIST